Skip to content

Resourcegroupss: effectiveness, costs and meaning

Resourcegroupss: effectiveness, costs and meaning

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON23275
Enrollment
200
Registered
2017-09-27
Start date
2017-10-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe mental illnessess

Interventions

The central element in the RG is the patient as the director of the group (Nordén et al., 2012b). That is, the patient nominates group-members sets his/her self-recovery treatment goals and decides on

Sponsors

Trimbos Instituut, Erasmus Medical Center, Arkin, Altrecht, GGZ Breburg, GGZ Centraal, GGZ Noord-Holland-Noord, Lentis, GGZ inGeest, BAVO Europoort, Antes.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Age between 18 – 65 years - Having a severe mental illness, defined as: (1) a diagnosable mental, behavioral, or emotional disorder according to the diagnostic criteria specified within the DSM-5, (2) that is associated with serious social and/or societal limitations, (3) in which the limitation is the cause and effect of the psychiatric disorder, (4) in which the psychiatric disorder has a chronic course; and (5) for which coordinated care of mental health care professionals in care networks is indicated to realize the treatment plan (Delespaul et al., 2013). - FACT-care for at least 18 months is indicated

Exclusion criteria

Exclusion criteria: - Unable to give informed consent - Insufficient knowledge of Dutch language

Design outcomes

Primary

MeasureTime frame
Empowerment

Secondary

MeasureTime frame
Quality of Life; General, social and societal functioning; Personal Recovery; Psychopathological symptoms; Attachment Style; Consumer Satisfaction; Use of Health Services;

Contacts

Public ContactCathelijn Tjaden
ctjaden@trimbos.nl0031-30-2959280

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)